These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32527703)

  • 21. Indian Health Service pharmacists engaged in opioid safety initiatives and expanding access to naloxone.
    Duvivier H; Gustafson S; Greutman M; Jangchup T; Harden AK; Reinhard A; Warshany K
    J Am Pharm Assoc (2003); 2017; 57(2S):S135-S140. PubMed ID: 28292501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient-Reported Goals of Youths in Canada Receiving Medication-Assisted Treatment for Opioid Use Disorder.
    Chai D; Rosic T; Panesar B; Sanger N; van Reekum EA; Marsh DC; Worster A; Thabane L; Samaan Z
    JAMA Netw Open; 2021 Aug; 4(8):e2119600. PubMed ID: 34351402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Provision of clinical pharmacist services for individuals with chronic hepatitis C viral infection: Joint Opinion of the GI/Liver/Nutrition and Infectious Diseases Practice and Research Networks of the American College of Clinical Pharmacy.
    Mohammad RA; Bulloch MN; Chan J; Deming P; Love B; Smith L; Dong BJ; GI Liver Nutrition and Infectious Diseases Practice and Research Networks of the American College of Clinical Pharmacy
    Pharmacotherapy; 2014 Dec; 34(12):1341-54. PubMed ID: 25359244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.
    Cole ES; DiDomenico E; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kim JY; Kmiec J; Kelley D; Donohue JM
    J Gen Intern Med; 2019 Jun; 34(6):936-943. PubMed ID: 30887440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient Reaction to Telemedicine for Clinical Management of Hepatitis C Virus Integrated into an Opioid Treatment Program.
    Talal AH; McLeod A; Andrews P; Nieves-McGrath H; Chen Y; Reynolds A; Sylvester C; Dickerson SS; Markatou M; Brown LS
    Telemed J E Health; 2019 Sep; 25(9):791-801. PubMed ID: 30325701
    [No Abstract]   [Full Text] [Related]  

  • 26. Predictors of Family Medicine Patient Retention in Opioid Medication-Assisted Treatment.
    Justesen K; A Hooker S; Sherman MD; Lonergan-Cullum M; Nissly T; Levy R
    J Am Board Fam Med; 2020; 33(6):848-857. PubMed ID: 33219064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral Prescription Opioids as a High-Risk Indicator for Hepatitis C Infection: Another Step Toward HCV Elimination.
    Hack B; Timalsina U; Tefera E; Wilkerson B; Paku E; Fernandez S; Fishbein D
    J Prim Care Community Health; 2021; 12():21501327211034379. PubMed ID: 34467805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial.
    Gustafson DH; Landucci G; McTavish F; Kornfield R; Johnson RA; Mares ML; Westergaard RP; Quanbeck A; Alagoz E; Pe-Romashko K; Thomas C; Shah D
    Trials; 2016 Dec; 17(1):592. PubMed ID: 27955689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PharmacistCARE: description of a pharmacist care service and lessons learned along the way.
    Divine H; Nicholas A; Johnson CL; Perrier DG; Steinke DT; Blumenschein K
    J Am Pharm Assoc (2003); 2008; 48(6):793-802. PubMed ID: 19019810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of embedding a pharmacist in a dermatology clinic on outcomes in a specialty pharmacy.
    Penick T; Hawkins T; O'Reilly E; Maniyar H; Maier C; McPheeters C
    J Am Pharm Assoc (2003); 2023; 63(2):661-666. PubMed ID: 36464555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advancing the implementation and sustainment of medication assisted treatment for opioid use disorders in prisons and jails.
    Ferguson WJ; Johnston J; Clarke JG; Koutoujian PJ; Maurer K; Gallagher C; White J; Nickl D; Taxman FS
    Health Justice; 2019 Dec; 7(1):19. PubMed ID: 31832801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between Medication Assisted Therapy Services Delivery and Mortality in a National Cohort of Veterans with Posttraumatic Stress Disorder and Opioid Use Disorder.
    Riblet NB; Gottlieb DJ; Shiner B; Cornelius SL; Watts BV
    J Dual Diagn; 2020; 16(2):228-238. PubMed ID: 31852392
    [No Abstract]   [Full Text] [Related]  

  • 33. Implementation of a medication therapy management program in a primary care clinic.
    Bowers BL; Heffern C; Billings S
    J Am Pharm Assoc (2003); 2019; 59(3):383-389. PubMed ID: 30954401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medication-Assisted Treatment for Opioid Use Disorder in a Rural Family Medicine Practice.
    Deyo-Svendsen M; Cabrera Svendsen M; Walker J; Hodges A; Oldfather R; Mansukhani MP
    J Prim Care Community Health; 2020; 11():2150132720931720. PubMed ID: 32507023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic content analysis of patient evaluations of START NOW psychotherapy reveals practical strategies for improving the treatment of opioid use disorder.
    Truong AY; Saway BF; Bouzaher MH; Rasheed MN; Monjazeb S; Everest SD; Giampalmo SL; Hartman D; Hartman C; Kablinger AS; Trestman RL
    BMC Psychiatry; 2021 Jan; 21(1):23. PubMed ID: 33423661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physician-pharmacist collaborative care model for buprenorphine-maintained opioid-dependent patients.
    DiPaula BA; Menachery E
    J Am Pharm Assoc (2003); 2015; 55(2):187-92. PubMed ID: 25749264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eight-hour medication-assisted treatment waiver training for opioid use disorder: integration into medical school curriculum.
    Lien IC; Seaton R; Szpytman A; Chou J; Webber V; Waineo E; Levine D
    Med Educ Online; 2021 Dec; 26(1):1847755. PubMed ID: 33222656
    [No Abstract]   [Full Text] [Related]  

  • 38. State targeted response to the opioid Crisis grants (opioid STR) program: Preliminary findings from two case studies and the national cross-site evaluation.
    High PM; Marks K; Robbins V; Winograd R; Manocchio T; Clarke T; Wood C; Stringer M
    J Subst Abuse Treat; 2020 Jan; 108():48-54. PubMed ID: 31303359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative effectiveness of pharmacist care delivery models for hepatitis C clinics.
    Naidjate SS; Zullo AR; Dapaah-Afriyie R; Hersey ML; Marshall BDL; Winkler RM; Berard-Collins C
    Am J Health Syst Pharm; 2019 May; 76(10):646-653. PubMed ID: 30873537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacist Comfort and Awareness of HIV and HCV Point-of-Care Testing in Community Settings.
    Min AC; Andres JL; Grover AB; Megherea O
    Health Promot Pract; 2020 Sep; 21(5):831-837. PubMed ID: 31257939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.